Infectious Bronchitis

Infectious Bronchitis is a highly contagious viral respiratory disease of chickens that causes significant economic losses in commercial poultry operations and affects backyard flocks worldwide. Caused by Infectious Bronchitis Virus (IBV), a coronavirus belonging to the family Coronaviridae, this disease spreads rapidly through flocks and can affect birds of all ages. The virus primarily targets the respiratory tract, causing clinical signs ranging from mild sneezing and nasal discharge to severe respiratory distress, but it can also damage the reproductive tract and kidneys, leading to production losses and, in some cases, significant mortality.

Infectious Bronchitis Virus exists in numerous serotypes and genotypes that continue to evolve and emerge globally. This extensive antigenic variation means that immunity to one IBV strain may provide little or no protection against other strains, making disease control particularly challenging. The virus spreads primarily through respiratory aerosols and can travel considerable distances on air currents, allowing it to jump rapidly between houses in multi-house facilities and even between neighboring farms. Contaminated equipment, clothing, and vehicles can also transport the virus mechanically. The high transmissibility of IBV means that once introduced to a susceptible flock, infection spreads throughout the population within days.

The impact of Infectious Bronchitis on affected flocks depends on the strain of virus involved, the age and immune status of the birds, and the presence of complicating factors such as secondary bacterial infections. In young chicks, the disease can cause severe respiratory distress with significant mortality, particularly when complicated by secondary infections. In laying hens, infection often causes dramatic drops in egg production along with severe deterioration in egg quality, including thin, misshapen, and rough-shelled eggs. Some IBV strains show tropism for the kidneys, causing nephritis that can result in high mortality. The economic losses from reduced production, increased mortality, and condemnations at processing make Infectious Bronchitis one of the most economically important poultry diseases globally.

There is no specific treatment for Infectious Bronchitis, as antibiotics are ineffective against viral infections. Management focuses on supportive care to maintain bird comfort and reduce mortality, along with prevention and control of secondary bacterial infections that commonly complicate cases. Vaccination is the primary means of prevention and is used extensively in commercial operations worldwide. However, the diversity of IBV strains means that vaccines must be carefully selected to match the strains circulating in a given region. Working with an avian veterinarian is essential for developing effective vaccination programs and managing outbreaks when they occur.

The primary cause of Infectious Bronchitis is infection with Infectious Bronchitis Virus (IBV), a positive-sense single-stranded RNA coronavirus. IBV was first identified in the United States in the 1930s and was actually the first coronavirus discovered in any species. The virus is classified in the genus Gammacoronavirus and is specific to chickens, not infecting other poultry species or mammals. The spike (S) protein on the virus surface determines antigenic properties and tissue tropism, and variations in this protein give rise to the many different serotypes and genotypes. The high mutation rate characteristic of RNA viruses, combined with recombination between strains, drives the continuous emergence of new IBV variants.

Genetic and species-related factors influence susceptibility to Infectious Bronchitis. While all chickens are susceptible to IBV infection, breed differences in disease severity have been noted. Some breeding lines may show greater resistance to specific IBV strains, though no breed is immune to infection. Age significantly affects disease expression, with young chicks showing more severe respiratory disease while older birds may show primarily reproductive or renal effects. Maternal antibodies provide some protection to young chicks if hens were vaccinated or previously exposed, but this protection is temporary and may interfere with early vaccination programs.

Environmental and husbandry factors play critical roles in Infectious Bronchitis transmission and disease severity. The virus is highly contagious and spreads rapidly through respiratory aerosols, with transmission occurring over distances of several meters through the air. Poor ventilation allows virus-laden aerosol particles to accumulate, increasing exposure levels. Overcrowding increases stress and the concentration of virus in the environment. Temperature extremes that stress birds increase susceptibility and disease severity. Ammonia from accumulated manure damages respiratory mucosa, predisposing to secondary bacterial infections that complicate IBV cases. The virus survives well in the environment under cool, humid conditions and can remain viable on contaminated surfaces for days.

Risk factors for Infectious Bronchitis outbreaks include the introduction of infected birds, inadequate biosecurity allowing virus entry on contaminated materials, proximity to other poultry operations, and inadequate or mismatched vaccination programs. Multi-age sites where birds of different ages are housed on the same premises have ongoing transmission as newly placed birds become infected by older, recovered birds still shedding virus. Wild birds, while not directly infected, may mechanically transport virus. Concurrent infections with immunosuppressive diseases such as infectious bursal disease increase susceptibility and severity. Seasonal factors may influence outbreak patterns, with some regions experiencing more problems during cooler months when virus survival is enhanced.

The mechanism of disease development begins when virus enters through the respiratory tract and replicates in the epithelial cells lining the trachea and bronchi. Initial viral replication causes inflammation and damage to the respiratory epithelium, manifesting as the classic respiratory signs of the disease. Viremia follows, allowing virus to spread to other target tissues. Some IBV strains preferentially infect the oviduct epithelium, causing damage that results in the characteristic egg production and quality problems. Nephropathogenic strains target the kidney tubules, causing nephritis and urate accumulation. The incubation period is short, typically 18 to 36 hours, explaining the rapid spread through flocks following introduction of infection.

Early warning signs of Infectious Bronchitis may be subtle and easily attributed to other causes before the disease becomes widespread in the flock. Initial signs often include decreased feed consumption that may precede obvious respiratory symptoms by several hours to a day. A few birds may show mild respiratory changes such as occasional sneezing or slight nasal discharge. Activity levels may decrease slightly, with birds appearing less active than usual. In laying flocks, a slight decrease in egg production may be the first indication of infection. The rapid spread of IBV means that early signs are quickly followed by widespread disease throughout the flock.

Common symptoms of Infectious Bronchitis in chickens include classic respiratory signs that become apparent as the disease spreads through the flock. Sneezing, coughing, and tracheal rales (rattling sounds) are characteristic and can often be heard when entering a chicken house. Watery nasal and ocular discharge develops, and affected birds may have wet feathers around the head from discharge accumulation. Labored breathing with open-mouth breathing occurs in more severe cases. Birds often appear depressed and may huddle together seeking warmth. Feed and water consumption typically decrease significantly during the acute phase of infection.

Behavioral changes in chickens with Infectious Bronchitis reflect the discomfort and debilitation caused by the infection. Affected birds become less active and may spend more time resting or huddling. Social interactions decrease as birds feel ill. Vocalization patterns change, with reduced crowing in roosters and less chattering among hens. Birds may shake their heads frequently due to nasal discharge. In laying hens, nest box visits may decrease or become irregular before production drops become apparent. The behavioral changes, combined with respiratory sounds, help distinguish IBV from other causes of decreased activity.

Physical signs of Infectious Bronchitis vary depending on the tissues affected and the strain of virus involved. Respiratory tract involvement produces nasal discharge, facial swelling in some cases, and accumulation of mucoid material in the trachea. In laying hens, egg production typically drops by 20 to 50 percent or more, and eggs produced during infection show characteristic quality defects including thin, soft, misshapen, or rough-textured shells. Shell color may be lighter than normal in brown-egg layers. Internal egg quality suffers, with watery albumen being common. Nephropathogenic strains cause wet droppings with high urate content, reflecting kidney damage and impaired water reabsorption.

Symptom progression in Infectious Bronchitis follows different patterns depending on the age of birds and strain of virus. In young chicks, respiratory signs predominate and may progress rapidly to severe respiratory distress, particularly when secondary bacterial infections develop. Mortality in young birds can be substantial, especially in broilers. In layers, respiratory signs typically peak within a week and then gradually resolve, while production effects may persist for weeks. Egg production usually begins recovering two to three weeks after infection but may not return to pre-infection levels. In flocks affected by nephropathogenic strains, signs of kidney failure may develop as respiratory signs begin to resolve.

Emergency symptoms requiring immediate veterinary attention include severe respiratory distress with open-mouth breathing and gasping, high mortality rates in young birds, or signs of kidney failure such as extreme depression, dehydration, and death. Mortality rates exceeding normal levels, particularly in young stock, warrant urgent investigation. Any situation where multiple birds show respiratory signs and production drops simultaneously should be evaluated promptly. While IBV itself is not treatable, early diagnosis allows for implementation of supportive care and control of secondary infections that can significantly reduce losses.

Initial examination for suspected Infectious Bronchitis involves assessment of both individual birds and flock performance parameters. The avian veterinarian will evaluate respiratory signs in affected birds, including listening for characteristic tracheal rales and examining the nares for discharge. Production records are reviewed to assess the pattern and magnitude of any egg production decline. Egg quality is evaluated, looking for the thin, misshapen, and rough-textured shells typical of IBV infection. The age of affected birds, flock history, vaccination status, and any recent changes or introductions are documented. In deceased birds, gross examination may reveal tracheal inflammation and exudate.

Diagnostic tests for Infectious Bronchitis include various methods to detect the virus and characterize the strain involved. Polymerase chain reaction (PCR) testing of tracheal or oropharyngeal swabs provides rapid, sensitive detection of IBV and is the most commonly used diagnostic method. Real-time PCR can provide quantitative results and may be used for strain typing. Virus isolation using embryonated chicken eggs remains the gold standard for definitive identification and is necessary for detailed strain characterization. Serological testing using ELISA or hemagglutination inhibition (HI) detects antibodies against IBV and can confirm flock exposure, with rising titers in paired samples indicating recent infection. Histopathology of respiratory tissues may reveal characteristic changes consistent with IBV infection.

Differential diagnosis for Infectious Bronchitis includes other respiratory diseases and conditions causing production decline in chickens. Newcastle disease causes similar respiratory signs but often includes neurological symptoms and higher mortality. Avian influenza produces respiratory signs and production drops but typically causes more severe systemic disease. Mycoplasma gallisepticum infection causes chronic respiratory disease with similar signs but slower progression. Infectious laryngotracheitis causes severe respiratory distress with bloody mucus. Aspergillosis may cause respiratory signs but is not contagious. Egg drop syndrome causes production and shell quality problems without respiratory signs. Environmental factors including ammonia exposure can cause respiratory irritation. Laboratory testing is essential for accurate diagnosis and appropriate response.

Diagnosis confirmation combines detection of IBV with compatible clinical presentation and exclusion of other causes. Positive PCR results from respiratory samples, combined with characteristic respiratory signs and production or quality effects, confirm active infection. Strain identification through sequencing or typing helps guide vaccination program adjustments. Rising antibody titers in paired serum samples demonstrate recent exposure in unvaccinated flocks. Once diagnosis is confirmed, the veterinarian advises on supportive care, secondary infection control, and vaccination program modifications to prevent future outbreaks with the identified strain.

Emergency treatment for Infectious Bronchitis focuses on maintaining bird comfort and reducing mortality through supportive care, as no antiviral medications are effective against IBV. Ensuring adequate environmental temperature is critical, as chilled birds are more susceptible to secondary infections and have higher mortality. Ventilation should maintain air quality while avoiding drafts that stress sick birds. Access to clean, fresh water must be maintained, and water soluble vitamins and electrolytes may help support sick birds. In severely affected flocks, reducing stocking density by removing healthy birds to other facilities may help reduce disease pressure if appropriate biosecurity can be maintained.

Medical management of Infectious Bronchitis centers on preventing and treating the secondary bacterial infections that commonly complicate viral respiratory disease. Antibiotics do not affect the virus itself but can significantly reduce mortality by controlling secondary infections with organisms such as Escherichia coli, Mycoplasma species, and other opportunistic bacteria. Antibiotic selection should be based on culture and sensitivity testing when possible, or on knowledge of common pathogens in the operation. Water medication is typically the most practical delivery method for flock-wide treatment. Treatment duration is usually five to seven days, though this may be extended based on clinical response.

Surgical options are not applicable for Infectious Bronchitis, as this is a viral infection affecting multiple body systems that cannot be addressed surgically. Resources and efforts are better directed toward supportive care, environmental management, and prevention of secondary infections. No surgical interventions exist that can alter the course of IBV infection. In some cases, culling of severely affected individuals may be the most humane option, particularly if birds are suffering without reasonable hope of recovery.

Supportive care forms the foundation of Infectious Bronchitis management and significantly impacts outcomes. Environmental management includes maintaining optimal temperature (warmer for young birds, comfortable for adults), ensuring good air quality by reducing ammonia levels, and providing adequate ventilation without drafts. Nutritional support ensures continued access to quality feed, though feed consumption often drops during acute illness. Water soluble vitamins, particularly vitamins A and E, support respiratory epithelial health and immune function. Electrolyte supplementation helps maintain hydration in birds with reduced water intake. Reducing stress through minimal handling and consistent routines supports immune function and recovery.

Alternative and complementary approaches for managing Infectious Bronchitis may include various supportive measures. Probiotics may help maintain gut health and support the immune system during respiratory illness. Herbal preparations and essential oils have been investigated for antimicrobial and immune-supporting properties, though evidence for efficacy against IBV is limited. Biosecurity measures to prevent introduction of additional pathogens reduce the risk of complicating secondary infections. The most important complementary approach is excellent husbandry that minimizes stress and maintains optimal environmental conditions for recovery.

Treatment decision factors for Infectious Bronchitis include the age and production status of affected birds, the severity of clinical signs, available resources for supportive care, and economic considerations. Young broilers with severe respiratory disease and high mortality may require intensive intervention including antibiotic therapy for secondary infections. Laying flocks may benefit from supportive care to minimize the duration and severity of production losses. Decisions about antibiotic use should consider withdrawal times for meat birds and regulations regarding egg discard during treatment. Vaccination program review and modification based on the strain identified is an important long-term management decision.

Recovery timeline for Infectious Bronchitis varies depending on the tissues affected and the presence of complications. Respiratory signs typically peak within five to seven days of infection and begin resolving over the following one to two weeks. Most birds recover from acute respiratory disease within two to three weeks, though coughing may persist longer in some individuals. Egg production in laying hens usually begins recovering two to three weeks after infection, but return to pre-infection production levels may take four to six weeks or longer. Some flocks never fully return to peak production following IBV infection, particularly if oviduct damage is severe.

Post-treatment care for flocks recovering from Infectious Bronchitis involves continued supportive management as birds heal. Monitoring for signs of secondary bacterial infections remains important throughout recovery, with prompt treatment if problems develop. Feed quality and availability should be optimized to support tissue repair and, in layers, return to production. Water quality should be maintained, and vitamin supplementation may continue during recovery. Environmental conditions should remain optimal, avoiding temperature stress and maintaining good air quality. Production and mortality records help track recovery progress and identify any ongoing problems.

Prognosis factors for Infectious Bronchitis recovery depend on several variables. Age at infection significantly affects outcomes, with young birds more susceptible to severe disease and mortality, while older birds typically recover well from respiratory disease. The IBV strain involved affects both severity and tissue tropism, with nephropathogenic strains causing higher mortality. Secondary bacterial infections dramatically worsen prognosis and must be controlled for good outcomes. Flock health status before infection, including nutritional status and presence of immunosuppressive diseases, influences recovery. Environmental conditions and supportive care quality significantly impact recovery rates and times.

Long-term outlook for flocks recovering from Infectious Bronchitis is generally favorable for surviving birds, though some lasting effects may persist. Respiratory epithelium regenerates, and most birds recover normal respiratory function. However, birds infected as young chicks may have permanent oviduct damage that prevents normal egg production at maturity. Kidney damage from nephropathogenic strains may cause ongoing health issues in some survivors. Recovered birds develop immunity to the infecting strain but remain susceptible to antigenically distinct IBV variants. This immunity contributes to flock protection but does not eliminate the need for vaccination against other circulating strains.

Environmental prevention of Infectious Bronchitis requires comprehensive biosecurity measures to prevent virus introduction. Controlling access to poultry houses with dedicated footwear and clothing for each house prevents tracking of virus between buildings. Vehicle and equipment disinfection prevents mechanical transmission on contaminated surfaces. All-in-all-out management with thorough cleaning and disinfection between flocks eliminates environmental virus reservoirs. Adequate distance between poultry operations reduces airborne transmission risk, though IBV can spread considerable distances. Wild bird exclusion prevents contact with potentially contaminated fecal material. Visitor restrictions and sign-in logs for biosecurity compliance help maintain protective protocols.

Quarantine protocols for Infectious Bronchitis prevention include careful management of bird introductions and isolation of any sick birds. While quarantine is less commonly practiced for chickens than for pet birds, commercial operations should avoid mixing birds from multiple sources. New additions to backyard flocks should be observed for signs of respiratory disease before introduction. Any birds showing respiratory signs should be isolated from the main flock pending diagnosis. During active outbreaks, movement of birds, equipment, and personnel between affected and unaffected houses should be strictly controlled.

Dietary prevention supports respiratory health and immune function to reduce disease susceptibility and improve outcomes following exposure. Complete, balanced nutrition appropriate for the age and production stage of birds provides the foundation for disease resistance. Vitamin A is particularly important for respiratory epithelial integrity; deficiency increases susceptibility to respiratory infections. Adequate vitamin E and selenium support immune function. Avoiding mycotoxin-contaminated feed prevents immunosuppression that increases disease susceptibility. Clean, fresh water provided through regularly cleaned delivery systems supports overall health.

Health maintenance through vaccination is the primary means of preventing Infectious Bronchitis in commercial and backyard flocks. Live attenuated vaccines are typically used in young birds, with application by spray, drinking water, or eye drop. Inactivated vaccines may be given to layers before production begins to boost immunity. The diversity of IBV strains means vaccine selection must be based on the strains circulating in the geographic region. Multiple serotypes are often included in vaccination programs to provide broader protection. Vaccine timing is critical, avoiding interference from maternal antibodies in young chicks while achieving immunity before exposure risk. Regular monitoring of antibody levels helps assess vaccination program effectiveness.

Early intervention when Infectious Bronchitis is suspected includes rapid diagnostic testing to confirm infection and identify the strain involved. Enhanced biosecurity measures prevent spread to other houses or flocks. Supportive care and secondary infection treatment are implemented promptly. Review and possible modification of the vaccination program based on the strain identified helps prevent future outbreaks. Documentation of the outbreak, including timing, clinical signs, and losses, provides information for future prevention planning. Communication with neighboring operations may be appropriate if there is risk of spread beyond the affected premises.

Daily management of flocks during and after Infectious Bronchitis outbreaks requires heightened attention to bird health and environmental conditions. Daily observation of each house or pen allows early detection of respiratory signs in new birds or recurrence in recovering flocks. Feed and water consumption should be monitored, as decreases may indicate ongoing disease or the development of secondary infections. Egg production and quality should be tracked to follow recovery progress in laying flocks. Mortality should be recorded and dead birds promptly removed and disposed of properly. Environmental conditions including temperature, humidity, and ammonia levels should be monitored and maintained within optimal ranges.

Home environment modifications for managing Infectious Bronchitis focus on supporting respiratory health and recovery. Ventilation should be optimized to provide fresh air while avoiding drafts, removing moisture and ammonia without chilling birds. Bedding should be kept dry, as wet litter increases ammonia production and respiratory irritation. Dust levels should be minimized through appropriate litter management. Temperature should be maintained at the comfort level for the age of birds, slightly warmer for sick birds. Stocking density should be appropriate for the housing system, with consideration for reducing density during outbreaks to decrease disease pressure.

Quality of life for birds affected by Infectious Bronchitis should be maintained to the extent possible during illness and recovery. Ensuring easy access to feed and water encourages continued intake even in sick birds. Comfortable environmental conditions reduce stress and support recovery. Birds showing severe respiratory distress or other signs of suffering should be humanely euthanized rather than allowed to experience prolonged distress. As flocks recover, normal activities and behaviors should return, and management can gradually return to standard practices.

Monitoring and ongoing care following Infectious Bronchitis outbreaks involves tracking flock recovery and watching for complications. Production records help assess the rate and extent of recovery in laying flocks. Respiratory signs should continue to improve; any recurrence or worsening warrants veterinary consultation. Secondary bacterial infections may develop during the recovery period and require treatment. Serological monitoring may be performed to assess flock immunity status and guide vaccination program decisions. Long-term observation of birds infected as chicks helps identify any permanent reproductive tract damage that prevents normal production.

Caregiver support during Infectious Bronchitis outbreaks includes access to veterinary guidance and industry resources. Commercial producers should work closely with veterinarians and company support staff to implement appropriate responses. Backyard flock owners can seek guidance from extension services, veterinarians, and online communities experienced in poultry health. Understanding that IBV is a common disease that most flocks recover from helps maintain perspective during outbreaks. Focusing on prevention through biosecurity and vaccination for future flocks provides a constructive approach following an outbreak. Documentation of losses may be needed for insurance purposes in commercial operations.

High-risk species for Infectious Bronchitis is primarily domestic chickens, which are the natural host for IBV. All breeds and types of chickens are susceptible, including commercial broilers, layers, and breeders, as well as backyard and exhibition birds. Young chicks under four weeks of age are at highest risk for severe respiratory disease and mortality. Layer pullets infected before reaching maturity may have permanent oviduct damage affecting lifetime production. Commercial operations with large numbers of birds housed at high density experience rapid disease spread and potentially significant economic losses. Birds that have not been vaccinated or are not immune to the circulating strain face higher risk of clinical disease.

Moderate-risk species for Infectious Bronchitis includes certain other gallinaceous birds that may be affected by IBV or closely related coronaviruses. Pheasants can be infected with some IBV strains and related coronaviruses, though disease is typically less severe than in chickens. Guinea fowl may be susceptible to some strains. Turkeys are not susceptible to chicken IBV but have their own coronavirus (turkey coronavirus) causing similar disease. Peafowl have been reported to show serological evidence of IBV exposure. Wild gallinaceous birds in areas of high poultry density may be exposed but do not appear to be important in disease maintenance or transmission.

Screening recommendations for Infectious Bronchitis in commercial operations include routine serological monitoring to assess flock immunity and vaccination program effectiveness. ELISA testing of serum samples at various stages of production helps track antibody levels. Monitoring should include comparison of titers between vaccinated and exposed birds to distinguish vaccine response from field challenge. When respiratory disease occurs, PCR testing provides rapid confirmation and strain identification. Sequencing of IBV isolates from the field helps ensure vaccination programs include appropriate strains. Backyard flock owners should consult with veterinarians about testing when respiratory disease occurs or before introducing new birds to existing flocks.

Commonly co-occurring conditions with Infectious Bronchitis typically involve secondary bacterial infections that complicate the viral disease. Escherichia coli airsacculitis and colisepticemia commonly develop following IBV infection, significantly increasing mortality and condemnations. Mycoplasma gallisepticum infection may occur concurrently, with the combined respiratory damage worse than either infection alone. Infectious bursal disease (IBD) suppresses immunity, making birds more susceptible to IBV and other infections. Poor environmental conditions that predispose to respiratory disease, such as high ammonia levels, often contribute to multiple concurrent respiratory problems. Managing these co-occurring conditions requires addressing both the viral infection through supportive care and the bacterial complications through appropriate antimicrobial therapy.

Conditions with similar symptoms to Infectious Bronchitis include various other respiratory diseases that must be differentiated for appropriate management. Newcastle disease causes respiratory signs and production drops but often includes neurological symptoms and higher mortality. Avian influenza, particularly low pathogenic strains, may present similarly but poses different regulatory and public health implications. Infectious laryngotracheitis causes more severe respiratory distress with characteristic bloody mucus. Mycoplasma gallisepticum causes chronic respiratory disease with similar but typically milder signs. Aspergillosis causes respiratory signs but is not contagious between birds. Environmental factors including poor air quality can cause respiratory irritation mimicking infectious disease. Laboratory diagnosis is essential for accurate identification and appropriate response.

Potential complications of Infectious Bronchitis extend beyond the acute disease and may have lasting impacts on affected flocks. Permanent oviduct damage in birds infected before maturity can cause lifelong production problems, including false layers that never produce eggs normally. Chronic respiratory disease may develop if secondary bacterial infections are not adequately controlled. Nephropathogenic IBV strains can cause chronic kidney damage in survivors. Airsacculitis and other complications may lead to condemnations at processing, causing economic losses beyond the acute disease phase. Preventing complications requires prompt supportive care, appropriate treatment of secondary infections, and vaccination programs designed to protect birds at vulnerable stages of development.